Comprehensive Registry of Esophageal Cancer in Japan, 2010.
Comprehensive Registry of Esophageal Cancer in Japan, 2010.
复制标题
DOI：
10.1007/s10388-017-0578-4
复制
发表时间：
2017
期刊：
影响因子：
--
通讯作者：
Registration Committee for Esophageal Cancer of the Japan Esophageal Society
中科院分区：
文献类型：
--
作者：
Tachimori Y;Ozawa S;Numasaki H;Ishihara R;Matsubara H;Muro K;Oyama T;Toh Y;Udagawa H;Uno T;Registration Committee for Esophageal Cancer of the Japan Esophageal Society
接受日期：2017年5月11日/在线发布日期：2017年5月19日© The Author（s）2017.本文是日本280个机构的开放获取出版物。肿瘤位置为颈部：4.3%，上胸：12.7%，中胸：48.8%，下胸：26.5%和EG连接处：6.5%。浅表癌（Tis、T1 a、T1 b）占34.9%。活检标本的组织学类型中，鳞癌和腺癌分别占90.5%和4.0%。关于临床结果，采用内镜粘膜切除术、同步放化疗或食管切除术治疗的患者的5年生存率分别为85.5%、27.3%和55.5%。食管切除术3564例。关于食管切除术的入路，30.4%的病例采用胸腔镜治疗。术后30天内手术死亡率为0.61%，住院死亡率为4.29%。我们希望2010年日本食管癌综合登记将有助于改善日本食管癌诊断和治疗的各个方面。
Accepted: 11 May 2017/Published online: 19 May 2017© The Author (s) 2017. This article is an open access publication280 institutions in Japan. Tumor locations were cervical: 4.3%, upper thoracic: 12.7%, middle thoracic: 48.8%, lower thoracic: 26.5% and EG junction: 6.5%. Superficial carcinomas (Tis, T1a, T1b) were 34.9%. As for the histologic type of biopsy specimens, squamous cell carcinoma and adenocarcinoma accounted for 90.5 and 4.0%, respectively. Regarding clinical results, the 5-year survival rates of patients treated using endoscopic mucosal resection, concurrent chemoradiotherapy, or esophagectomy were 85.5, 27.3, and 55.5%, respectively. Esophagectomy was performed in 3564 cases. Concerning the approach used for esophagectomy, 30.4% of the cases were treated thoracoscopically. The operative mortality (within 30 days after surgery) was 0.61% and the hospital mortality was 4.29%. We hope that this Comprehensive Registry of Esophageal Cancer in Japan for 2010 will help to improve all aspects of the diagnosis and treatment of esophageal cancer in Japan.